Ouch! US Lashes Out At China With New Tariffs On Selected Drugs, APIs
Executive Summary
The Office of the US Trade Representative has released plans to impose new higher tariffs on 1,300 products from China accounting for exports totaling $50bn. Certain active pharmaceutical ingredients and drugs on the list face an additional 25% tariff if the plan is implemented, prompting China to say it will soon announce retaliation measures, and the potential impact on US drugs and medical devices is surely a cause for concern.